» Articles » PMID: 36305054

Semantic and Acoustic Markers in Schizophrenia-Spectrum Disorders: A Combinatory Machine Learning Approach

Overview
Journal Schizophr Bull
Specialty Psychiatry
Date 2022 Oct 28
PMID 36305054
Authors
Affiliations
Soon will be listed here.
Abstract

Background And Hypothesis: Speech is a promising marker to aid diagnosis of schizophrenia-spectrum disorders, as it reflects symptoms like thought disorder and negative symptoms. Previous approaches made use of different domains of speech for diagnostic classification, including features like coherence (semantic) and form (acoustic). However, an examination of the added value of each domain when combined is lacking as of yet. Here, we investigate the acoustic and semantic domains separately and combined.

Study Design: Using semi-structured interviews, speech of 94 subjects with schizophrenia-spectrum disorders (SSD) and 73 healthy controls (HC) was recorded. Acoustic features were extracted using a standardized feature-set, and transcribed interviews were used to calculate semantic word similarity using word2vec. Random forest classifiers were trained for each domain. A third classifier was used to combine features from both domains; 10-fold cross-validation was used for each model.

Results: The acoustic random forest classifier achieved 81% accuracy classifying SSD and HC, while the semantic domain classifier reached an accuracy of 80%. Joining features from the two domains, the combined classifier reached 85% accuracy, significantly improving on separate domain classifiers. For the combined classifier, top features were fragmented speech from the acoustic domain and variance of similarity from the semantic domain.

Conclusions: Both semantic and acoustic analyses of speech achieved ~80% accuracy in classifying SSD from HC. We replicate earlier findings per domain, additionally showing that combining these features significantly improves classification performance. Feature importance and accuracy in combined classification indicate that the domains measure different, complementing aspects of speech.

Citing Articles

Changes in the structure of spontaneous speech predict the disruption of hierarchical brain organization in first-episode psychosis.

He R, Alonso-Sanchez M, Sepulcre J, Palaniyappan L, Hinzen W Hum Brain Mapp. 2024; 45(14):e70030.

PMID: 39301700 PMC: 11413563. DOI: 10.1002/hbm.70030.


Natural Language Processing and Schizophrenia: A Scoping Review of Uses and Challenges.

Deneault A, Dumais A, Desilets M, Hudon A J Pers Med. 2024; 14(7).

PMID: 39063998 PMC: 11278236. DOI: 10.3390/jpm14070744.


Linguistic findings in persons with schizophrenia-a review of the current literature.

Ehlen F, Montag C, Leopold K, Heinz A Front Psychol. 2023; 14:1287706.

PMID: 38078276 PMC: 10710163. DOI: 10.3389/fpsyg.2023.1287706.


Trajectories through semantic spaces in schizophrenia and the relationship to ripple bursts.

Nour M, McNamee D, Liu Y, Dolan R Proc Natl Acad Sci U S A. 2023; 120(42):e2305290120.

PMID: 37816054 PMC: 10589662. DOI: 10.1073/pnas.2305290120.


Validation of natural language processing methods capturing semantic incoherence in the speech of patients with non-affective psychosis.

Just S, Brocker A, Ryazanskaya G, Nenchev I, Schneider M, Bermpohl F Front Psychiatry. 2023; 14:1208856.

PMID: 37564246 PMC: 10411549. DOI: 10.3389/fpsyt.2023.1208856.


References
1.
Voppel A, de Boer J, Brederoo S, Schnack H, Sommer I . Quantified language connectedness in schizophrenia-spectrum disorders. Psychiatry Res. 2021; 304:114130. DOI: 10.1016/j.psychres.2021.114130. View

2.
Sheehan D, Lecrubier Y, Sheehan K, Amorim P, Janavs J, Weiller E . The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry. 1999; 59 Suppl 20:22-33;quiz 34-57. View

3.
de Boer J, Voppel A, Brederoo S, Schnack H, Truong K, Wijnen F . Acoustic speech markers for schizophrenia-spectrum disorders: a diagnostic and symptom-recognition tool. Psychol Med. 2021; 53(4):1302-1312. PMC: 10009369. DOI: 10.1017/S0033291721002804. View

4.
Rubio J, Schoretsanitis G, John M, Tiihonen J, Taipale H, Guinart D . Psychosis relapse during treatment with long-acting injectable antipsychotics in individuals with schizophrenia-spectrum disorders: an individual participant data meta-analysis. Lancet Psychiatry. 2020; 7(9):749-761. DOI: 10.1016/S2215-0366(20)30264-9. View

5.
Oomen P, de Boer J, Brederoo S, Voppel A, Brand B, Wijnen F . Characterizing speech heterogeneity in schizophrenia-spectrum disorders. J Psychopathol Clin Sci. 2022; 131(2):172-181. DOI: 10.1037/abn0000736. View